We developed a new fully automated ion-exchange chromatographic method for quantitating carbohydratedeficient transferrin (CDT) on a Mono Q column. Quantitation relies on the selective absorbance of the irontransferrin complex at 460 nm. Transferrin isoforms deficient in sialic acid, with pls 5.7 and 5.9, can easily be separated and quantitated as a percentage of the total transferrin. This method has been applied to samples from teetotalers, occasional drinkers, patients with recent heavy alcohol consumption, and patients during detoxification. The sensitivity of the method was 55% in patients reporting 40-70 g daily ethanol consumption and nearly 100% in heavily intoxicated patients (70-500 g daily consumption). The half-life of the dominating p15.7 isoform in this group was 9.5 (± 1) days during detoxification. A CDT value > 0.8% is a highly specific marker for alcohol abuse and is greatly superior to other currently available biological markers. (5 SA), p15.4(4 SA, major fraction), p15.6(3 SA), and p1 5.7(2 SA). The p15.7 fraction is normally <0.8% of total transferrin, but may be increased more than 10-fold after heavy alcohol consumption. After excessive drinking an additional p15.9 fraction (0 SA) may appear. The p15.7 and p15.9 fractions are called carbohydrate-deficient transferrin (CDT). The purpose of this investigation was to develop an HPLC method for routine laboratories to identify subjects at high risk for alcohol (ethanol) dependence and to evaluate its sensitivity and specificity for detecting heavy alcohol consumption in defined populations.
Preparation of Samples
Fresh serum or serum frozen at -20 #{176}C for <6 months was saturated with iron by adding 25 L of NaHCO3 
Equipment
The HPLC system consisted of pump no. 2941 (Pharmacia Biotechnology, Uppsala, Sweden), a Jasco (Tokyo, Japan) 870 UV detector equipped with a 460-nm filter, and a 10-mm flow cell together with a tungsten lamp. The system contained an autounjector, Waters (Milford, MA) WISP 715, with a cooling system for 96 samples. A Shimadzu (Tokyo, Japan) CR 5A integrator was used for calculating the peak areas according to the valley-valley mode.
Procedure
Ion-exchange chromatography.
The transferrin isoforms were separated on a Mono Q HR 5/5 column (Pharmacia) by salt gradient elution; the process took 32 miii, including regeneration.
Starting buffer (A) was Bis-Tris, 20 mmoWL, pH 6.2. Buffer B was buffer A plus NaC1, 350 mmol/L, at the same pH. Solution C, NaC1, 1 molIL , was used for regeneration.
Before use, all solutions were degassed and filtered through a 0.45-sm (pore-size) filter. Samples (200 tL) were injected, the flow rate was maintained at 1 mldmin, providing the gradient profile shown in Table 1 , and the monitor sensitivity range was 0.01 A fill scale.
Once a week the entire system excluding the Mono Q column was flushed with a 40 mmol/L solution of sodium hypochlorite.
After -50 patients' samples, the Mono Q column was regenerated according to the manufacturer's instructions:
pepsin (1 g/L) in acetic acid (100 mmolfL) containing sodium chloride (500 mmol/L) was pumped through the column with a retrograde flow rate of 1 midmin for 10 mm. The column ends were sealed and the whole column was stored at 37#{176}C overnight. After the enzymatic treatment, conventional regeneration with sodium chloride, sodium hydroxide, and acetic acid was performed.
The autoinjector was used to deliver the different solutions. Regeneration was terminated by antegrade flushing with solution C for 10 miii.
If the backpressure stifi exceeded 4 mPa, the top filter assembly in the column was replaced. The absorbance was registered at 460 nm and peak areas were automatically integrated.
The sum of areas for all transferrin isoforms was considered as 100% and areas for individual isoforms were reported as a percentage of the total amount of transferrin. The shaded peaks show the carbohydrate-deficientIsotormsp15.7 (*) and p1 5.9 (").The absorbanceof the Fe-transfenln complex was measuredat 460 nm pattern.
The absorbance of the Fe-transferrun complex at 460 nm is -10% of the 280 nm absorbance but is highly specific for the transferrin fractions. The amount of CDT atpl 5.7 represents only 0.2-0.8% (mean ±2 SD) of the total transferrin in teetotalers and moderate drinkers.
This value was slightly dependent on the method of integration of the chromatography profile. Slightly higher values were found with baseline integration, but the valley-valley method was more reproducible and less dependent on matrix effects. The CVs are given in Table 2 .
IEF of CDT
Removal of albumin eliminates the need for immunoflxation to visualize the specific transferrin isoforms. Lane S in Figure 2 represents an untreated serum sample with the diffuse albumin shadow that may sometimes cover the p1 5.7 isoform. Lanes 0, 2, 4, 8, and 13 show the complete disappearance of the p1 5.9 isoform and the gradually decreasing p15.7 isoform from day 0 to day 13. The IEF procedure is used to veriEy genetic variants that appear as abnormal chromatography proifies. All patients with CDT >1% showed increased intensity of the p1 5.7 fraction on IEF. Several genetic variants appeared, mostly subtypes of transferrin C togather with a few cases of heterozygotes BC (lower pI) and CD (higher p1).
Catabolic Rate of CDT
The disappearance rate of CDT was determined by measuring the p1 5.7 CDT of four heavily intoxicated The half-life was determined from the linear slope of each curve. There was little difference between individual patients; the mean half-life was 9.5 ± 1 days. CDT values found in samples from teetotalers and occasional drinkers (laboratory stafi) showed a normal distribution and were consistently <1% by valley-valley integration (Figure 4) . Among the 284 men from the general city population with a previous record of high GGT values, 20% declared an alcohol consumption of 40-70 g/24 h. In these men the sensitivity of CDT was 55% and the specificity 91%, for the cutoff value of 0.8%. heavily intoxicated drinkers (70-500 g/24 h 
Among the

Clinical Application
Depending on the examined population, the sensitivity and specificity of CDT varies. According to Stibler (11), a sensitivity of 82% and a specificity of 97% have been achieved with all the methods used so far. In a population examined at a general medical practice (27) in which the subjects had a wide range of alcohol consumption, the sensitivity decreased to -45%. This has also been the case in two reports from the general population in Norway (28) and Finland (29). Quite a low sensitivity, especially in young individuals, was found in the Finnish study. In our evaluated population of middle-aged men, the individuals have been very thoroughly characterized and followed over 15 years. At the follow-up in 1991, the alcohol consumption was assessed by two trained nurses and blood was sampled for CDT at the same occasion. We found a sensitivity of 55% in the group that reported an alcohol consumption of >40 g/day. However, in the study of intoxicated individuals consuming >70 g/day, the sensitivity was near 100%, which is in agreement with Stibler's results (11). The high specificity in the teetotalers and the occasional drinkers, near 100%, allows the conclusion that CDT has the highest specificity of the available biological markers.
